Topiramate in benzodiazepine withdrawal

被引：15
作者：
Cheseaux, M
Monnat, M
Zullino, DF [1 ]
机构：
[1] Dept Univ Psychiat Adulte, Div Abus Subst, Clin Cery, CH-1008 Prilly, Switzerland
[2] Policlin Med Univ, Lausanne, Switzerland
来源：
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL | 2003年 / 18卷 / 05期
关键词：
anticonvulsant; substance abuse; AMPA receptor; benzodiazepine withdrawal; detoxitication;
D O I：
10.1002/hup.497
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
There is an increasing interest in anticonvulsants for the treatment of benzodiazepine withdrawal symptoms. The new anticonvulsant compound topiramate seems to be an especially promising drug for this indication. It acts, among others, as an AMPA antagonist, which may be responsible in part for its anticonvulsant efficacy, but may also modulate the withdrawal-induced activation of noradrenergic neurons in the locus coeruleus, which are related to some behavioural effects of benzodiazepine withdrawal. A case is presented of a rapid benzodiazepine-withdrawal treated successfully with topiramate. Copyright (C) 2003 John Wiley Sons, Ltd.
引用
收藏
页码：375 / 377
页数：3
相关论文
共 15 条
  • [1] KLEIN E, 1986, AM J PSYCHIAT, V143, P235
  • [2] KRENZ SL, 2002, EUR PSYCHIAT, V17, P213
  • [3] Topiramate - A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of epilepsy
    Langtry, HD
    Gillis, JC
    Davis, R
    [J]. DRUGS, 1997, 54 (05) : 752 - 773
  • [4] COMBINATION THERAPY WITH CARBAMAZEPINE BENZODIAZEPINE FOR POLYDRUG ANALGESIC DEPRESSANT WITHDRAWAL
    LICHTIGFELD, FJ
    GILLMAN, MA
    [J]. JOURNAL OF SUBSTANCE ABUSE TREATMENT, 1991, 8 (04) : 293 - 295
  • [5] Carbamazepine normalizes the altered behavioral and neurochemical response to stress in benzodiazepine-withdrawn rats
    Martijena, ID
    Lacerra, C
    Molina, VA
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 330 (2-3) : 101 - 108
  • [6] Neurobiology - Total recall - The memory of addiction
    Nestler, EJ
    [J]. SCIENCE, 2001, 292 (5525) : 2266 - 2267
  • [7] RASMUSSEN K, 1995, NEUROPSYCHOPHARMACOL, V13, P295, DOI 10.1016/0893-133X(95)00082-O
  • [8] Pharmacologic strategies for discontinuing benzodiazepine treatment
    Rickels, K
    DeMartinis, N
    Rynn, M
    Mandos, L
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1999, 19 (06) : 12S - 16S
  • [9] Trazodone and valproate in patients discontinuing long-term benzodiazepine therapy:: effects on withdrawal symptoms and taper outcome
    Rickels, K
    Schweizer, E
    España, FG
    Case, G
    DeMartinis, N
    Greenblatt, D
    [J]. PSYCHOPHARMACOLOGY, 1999, 141 (01) : 1 - 5
  • [10] RIES RK, 1989, AM J PSYCHIAT, V146, P536
12